Sign in

CIK 0001725160 · Non-accelerated filer<br>Smaller reporting company

Zentalis Pharmaceuticals, Inc.

Sign in to watch
Ticker
ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
823607803
Phone
(858) 263-4333
Business address
10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-09-16 Gallagher Cam President Sale −8,866 $24.38 $216K 445,519
2022-09-16 Gallagher Cam President Sale −1,134 $24.99 $28K 444,385
2022-09-15 Gallagher Cam President Sale −8,426 $25.10 $212K 458,459
2022-09-15 Gallagher Cam President Sale −4,074 $25.59 $104K 454,385
2022-09-09 Skvarka Jan Director Grant or award +36,606 36,606
2022-08-10 Bunker Kevin D. Chief Operating Officer Sale −5,000 $30.00 $150K 95,000
2022-08-01 Paul Andrea General Counsel Grant or award · Stock Option (Right to Buy) +290,500 290,500
2022-07-20 Bunker Kevin D. Chief Operating Officer Sale −5,000 $30.00 $150K 100,000
2022-07-14 Bunker Kevin D. Chief Operating Officer Sale −3,290 $30.01 $99K 105,000
2022-07-13 Bunker Kevin D. Chief Operating Officer Sale −1,710 $30.02 $51K 108,290
2022-07-05 Bunker Kevin D. Chief Operating Officer Sale −25,000 $30.07 $752K 110,000
2022-06-08 Johnson David Michael Director Grant or award +24,871 108,330
2022-06-08 Kariuki Enoch Director Grant or award +21,817 21,817
2022-05-30 Gallagher Cam President Grant or award +111,072 466,885
2022-05-30 Gallagher Cam President Grant or award · Stock Option (Right to Buy) +333,218 333,218
2022-05-16 Blackwell Kimberly President & CEO Grant or award · Stock Option (Right to Buy) +1,708,809 1,708,809
2022-05-16 Blackwell Kimberly President & CEO Grant or award · Stock Option (Right to Buy) +427,202 427,202
2022-04-11 Bunker Kevin D. Chief Operating Officer Sale −4,600 $30.37 $140K 135,400
2022-04-11 Bunker Kevin D. Chief Operating Officer Sale −300 $32.40 $10K 135,100
2022-04-11 Bunker Kevin D. Chief Operating Officer Sale −100 $33.16 $3K 135,000

Page 8 of 8 · 160 trades